Skip to main content
SpringerLink
Log in

Cardiac resynchronisation therapy and the role of optimal device utilisation

  • Interuniversity Cardiology Institute of the Netherlands
  • Published:
Netherlands Heart Journal Aims and scope Submit manuscript

Abstract

Despite established selection criteria, 30 to 40% of patients do not respond to cardiac resynchronisation therapy. By optimising programming of the device response to cardiac resynchronisation, therapy can be improved. (Neth Heart J 2009;17:354–7.)

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Manolis AS. Cardiac resynchronization therapy in congestive heart failure: Ready for prime time? Heart Rhythm. 2004;1:355–63.

    Google Scholar 

  2. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350:2140–50.

    Google Scholar 

  3. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005;352:1539–49.

    Google Scholar 

  4. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail. 2008;10:933–89.

    Google Scholar 

  5. Ypenburg C, van Bommel RJ, Delgado V, Mollema SA, Bleeker GB, Boersma E, et al. Optimal left ventricular lead position predicts reverse remodeling and survival after cardiac resynchronization therapy. J Am Coll Cardiol. 2008;52:1402–9.

    Google Scholar 

  6. Buck S, Maass AH, Nieuwland W, Anthonio RL, van Veldhuisen DJ, Van Gelder IC. Impact of interventricular lead distance and the decrease in septal-to-lateral delay on response to cardiac resynchronization therapy. Europace. 2008;10:1313–9.

    Google Scholar 

  7. Mair H, Sachweh J, Meuris B, Nollert G, Schmoeckel M, Schuetz A, et al. Surgical epicardial left ventricular lead versus coronary sinus lead placement in biventricular pacing. Eur J Cardiothorac Surg. 2005;27:235–42.

    Google Scholar 

  8. Sawhney NS, Waggoner AD, Garhwal S, Chawla MK, Osborn J, Faddis MN. Randomized prospective trial of atrioventricular delay programming for cardiac resynchronization therapy. Heart Rhythm. 2004;1:562–7.

    Google Scholar 

  9. Maass AH, Buck S, Nieuwland W, Brügemann J, van Veldhuisen DJ, Van Gelder IC. Importance of Heart Rate During Exercise for Response to Cardiac Resynchronization Therapy. J Cardiovasc Electrophysiol. 2009.

  10. Gasparini M, Auricchio A, Metra M, Regoli F, Fantoni C, Lamp B, et al. Long-term survival in patients undergoing cardiac resynchronization therapy: the importance of performing atrio-ventricular junction ablation in patients with permanent atrial fibrillation. Eur Heart J. 2008;29:1644–52.

    Google Scholar 

  11. Khadjooi K, Foley PW, Chalil S, Anthony J, Smith RE, Frenneaux MP, et al. Long-term effects of cardiac resynchronisation therapy in patients with atrial fibrillation. Heart. 2008;94:879–83.

    Google Scholar 

  12. Buck S, Rienstra M, Maass AH, Nieuwland W, van Veldhuisen DJ, van Gelder IC. Cardiac resynchronization therapy in patients with heart failure and atrial fibrillation: importance of new-onset atrial fibrillation and total atrial conduction time. Europace. 2008;10:558–65.

    Google Scholar 

  13. Borleffs CJ, Ypenburg C, van Bommel RJ, Delgado V, van Erven L, Schalij MJ, et al. Clinical importance of new-onset atrial fibrillation after cardiac resynchronization therapy. Heart Rhythm. 2009;6:305–10.

    Google Scholar 

  14. Ellery S, Pakrashi T, Paul V, Sack S. Predicting mortality and rehospitalization in heart failure patients with home monitoring—the Home CARE pilot study 1. Clin Res Cardiol. 2006;95 Suppl 3:III29–III35.

    Google Scholar 

  15. Ricci RP, Morichelli L, Santini M. Remote control of implanted devices through Home Monitoring technology improves detection and clinical management of atrial fibrillation. Europace. 2009;11:54–61.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. www.bsl.nl/shop/

    S. Buck

Authors
  1. S. Buck
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. H. Maass
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D. J. van Veldhuisen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. I. C. Van Gelder
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands

Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, and the Interuniversity Cardiology Institute Netherlands, Utrecht, the Netherlands

I.C. Van Gelder Department of Cardiology, Thoraxcenter, University Medical Center Groningen, University of Groningen, PO Box 30.001, 9700 RB Groningen, the Netherlands

Rights and permissions

Reprints and permissions

About this article

Cite this article

Buck, S., Maass, A.H., van Veldhuisen, D.J. et al. Cardiac resynchronisation therapy and the role of optimal device utilisation. NHJL 17, 354–357 (2009). https://doi.org/10.1007/BF03086283

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03086283

Search

Navigation